Oncology Start-up Cyterix Pharmaceuticals Launches With $9.2MM From VCs
This article was originally published in The Pink Sheet Daily
Executive Summary
Two venture firms bet on the Scottish university spin-out, now based California, as it develops pro-drugs activated by a specific enzyme family.